Myovant scores FDA nod for Orgovyx, a first-in-class pill for advanced prostate cancer esagonowsky Mon, 12/21/2020 – 11:31 More: Myovant scores FDA nod for Orgovyx, a first-in-class pill for advanced prostate cancer Source: fierce
read moreWuXi lays out €150M to take over Bayer plant in Germany, boosting pandemic supply network fkansteiner Mon, 12/21/2020 – 11:29 More: WuXi lays out €150M to take over Bayer plant in Germany, boosting pandemic supply network Source: fierce
read morePick the Commish: Fierce Pharma voters select Amy Abernethy for next FDA chief bbulik Mon, 12/21/2020 – 10:40 More: Pick the Commish: Fierce Pharma voters select Amy Abernethy for next FDA chief Source: fierce
read moreCodagenix, Serum Institute take nasal COVID-19 vaccine into clinic ntaylor Mon, 12/21/2020 – 09:48 More: Codagenix, Serum Institute take nasal COVID-19 vaccine into clinic Source: fierce
read moreAstraZeneca, FibroGen’s roxadustat hits snag at FDA, but analysts figure an approval’s still on its way esagonowsky Mon, 12/21/2020 – 09:33 More: AstraZeneca, FibroGen's roxadustat hits snag at FDA, but analysts figure an approval's still on its way Source: fierce
read moreTreatment demonstrated non-inferior visual acuity gains compared to Regeneron’s Eylea More: Roche’s faricimab hits the mark in diabetic macular edema study Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals